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ABSTRACT
Background. Kidney transplantation is the treatment of choice
to restore fertility to women on renal replacement therapy. Over
time, immunosuppressive, support therapies and approaches to-
wards high-risk pregnancies have changed. The aim of this study
was to analyse maternal–foetal outcomes in two cohorts of trans-
planted women who delivered a live-born baby in Italy in 1978–
2013, dichotomized into delivery before and after January 2000.
Methods. A survey involving all the Italian transplant centres
was carried out, gathering data on all pregnancies recorded
since the start of activity at each centre; the estimated nation-
wide coverage was 75%. Data on cause of ESRD, dialysis, liv-
ing/cadaveric transplantation, drug therapy, comorbidity, and
the main maternal–foetal outcomes were recorded and re-
viewed. Data were compared with a low-risk cohort of
pregnancies from two large Italian centres (2000–14; Torino
and Cagliari Observational Study cohort).
Results. The database consists of 222 pregnancies with live-
born babies after transplantation (83 before 2000 and 139 in
2000–13; 68 and 121 with baseline and birth data, respectively),
and 1418 low-risk controls. The age of the patients signiﬁcantly
increased over time (1978–99: age 30.7 ± 3.7 versus 34.1 ± 3.7 in
2000–13; P < 0.001). Azathioprine, steroids and cyclosporine A
were the main drugs employed in the ﬁrst time period, while ta-
crolimus emerged in the second. The prevalence of early preterm
babies increased from 13.4% in the ﬁrst to 27.1% in the second
period (P = 0.049), while late-preterm babies non-signiﬁcantly de-
creased (38.8 versus 33.1%), thus leaving the prevalence of all pre-
term babies almost unchanged (52.2 and 60.2%; P = 0.372). Babies
below the 5th percentile decreased over time (22.2 versus 9.6%;
P = 0.036). In spite of high prematurity rates, no neonatal deaths
O
R
IG
IN
A
L
A
R
T
IC
L
E
© The Author 2016. Published by Oxford University Press
on behalf of ERA-EDTA. All rights reserved.
1957
 by A
ntonello Pani on D
ecem
ber 1, 2016
http://ndt.oxfordjournals.org/
D
ow
nloaded from
 
occurred after 2000. The results in kidney transplant patients
are signiﬁcantly different from controls both considering all
cases [preterm delivery: 57.3 versus 6.3%; early preterm: 22.2
versus 0.9%; small for gestational age (SGA): 14 versus 4.5%;
P < 0.001] and considering only transplant patients with normal
kidney function [preterm delivery: 35 versus 6.3%; early preterm:
10 versus 0.9%; SGA: 23.7 versus 4.5% (P < 0.001); risks increase
across CKD stages]. Kidney function remained stable in most of
the patients up to 6months after delivery.Multiple regression ana-
lysis performed on the transplant cohort highlights a higher risk of
preterm delivery in later CKD stages, an increase in preterm deliv-
ery and a decrease in SGA across periods.
Conclusions. Pregnancy after transplantation has a higher risk
of adverse outcomes compared with the general population.
Over time, the incidence of SGA babies decreased while the in-
cidence of ‘early preterm’ babies increased. Although acknow-
ledging the differences in therapy (cyclosporine versus
tacrolimus) and in maternal age (signiﬁcantly increased), the
decrease in SGA and the increase in prematurity may be ex-
plained by an obstetric policy favouring earlier delivery against
the risk of foetal growth restriction.
BACKGROUND
Kidney transplantation is frequently cited as the best way to re-
store fertility in a woman with severe CKD or on renal replace-
ment therapy (RRT) [1–6]. However, in spite of decades of
clinical experience, several problems remain unsolved, and
counselling may still be difﬁcult, given also the important dif-
ferences in culture and in clinical management all over the
world [5, 7–13]. Despite the availability of large databases, sys-
tematic reviews and guidelines, the need for new data as under-
lined by an editorial in 2010 is still felt [14].
Kidney transplantation and obstetric care are ﬁelds under-
going continuous evolution, and these changesmay be relevant
for interpretation of results that are mainly based on large, his-
torical databases/registries or on single-centre series often en-
compassing several decades [15–20]. A recent, large systematic
review of 50 papers from 25 countries highlighted some of the
limitations of the present evidence, including patient overlap
between studies; unmeasured, confounding differences in clas-
siﬁcation criteria, in particular for pre-eclampsia, baseline and
pregnancy-induced hypertension; and selection and/or report-
ing biases mainly linked to the fact that most of the registries
are voluntary [21]. Only 6 papers of the 50 analysed provided
information on at least 100 pregnancies, thus underlining the
need for gathering further large patient series [21].
In many western countries, the age of women undertaking
pregnancy has progressively increased and the advances in ma-
ternal–foetal medicine have anticipated timing of a ‘viable’ de-
livery, easing the way to pregnancies in chronic diseases at high
risk for preterm delivery and low birthweight [22–26]. High-
risk pregnancies are thus increasing in several conditions, in-
cluding CKD and dialysis, reaching previously unmet targets
while presenting new challenges [27–30]. Chronic dialysis is
one of the ﬁelds in which the advances are most dramatic,
not only in terms of the incidence of live-born babies, but
also with regard to the reduction in severe prematurity, in par-
ticular with the new long dialysis approaches [28].
According to two recent studies from almost opposite re-
gions of the world (Italy and Australia), the probability of giving
birth to a live-born baby is between 10 and 20% for a kidney graft
patient as compared to the general population (in turn about 10
times higher as compared to dialysis) [31, 32]. While pregnancies
are increasing in dialysis patients, the advances in transplantation
have probably affected fertility and pregnancy-related outcomes
less, and both are still less favourable as compared with the overall
population. However, few studies are speciﬁcally addressed to
these issues and, in particular, the differences occurring over
time, with speciﬁc regard to the obstetric policy have never
been extensively analysed [18, 22, 33–35]. An analysis of the ob-
served changes could provide an additional key for interpretation
of the available evidence, potentially adding to our knowledge on
the reasons why maternal–foetal outcomes are still different with
regard to low-risk pregnancies [21, 36].
This multicentre, nationwide collaborative study was de-
signed to analyse the changes in maternal–foetal outcomes of
pregnancies after kidney transplantation that have taken place
since the start of kidney transplantation in Italy (1978–2013).
MATERIALS AND METHODS
Study design and source of data
The present study was planned in the context of the activities
of the study group ‘Kidney and Pregnancy’ of the Italian Society
of Nephrology in collaboration with the study group on kidney
transplantation.
In the absence of a national registry gathering data on preg-
nancy after renal transplantation, the present analysis was based
on a survey involving all the Italian transplant centres (37 cen-
tres, all of which are public; 24 answered).
The coverage of the transplant population was estimated at
∼60% in the period prior to 2000 and at ∼80% between 2000
and 2013. In the latter period, >95% of the patients were trans-
planted in Italian centres, and most of them were grafted at the
nearest regional centre.The coveragehas increased since theprevi-
ousnationwide study that focusedonpregnancyafter dialysis [31].
Collected data
The following information was selected: code, centre, date of
birth, date of RRT start, type of kidney disease, gestational age,
birthweight, preterm delivery, small for gestational age (SGA),
follow-up of the mother [functioning graft, on dialysis, dead (in
the case of death, date and cause death)] and of the child. Func-
tional data [serum creatinine, GFR (calculated according to the
Chronic Kidney Disease Epidemiology Collaboration) were
gathered at the start of pregnancy, at 20 weeks, at delivery
and 6 months after delivery; blood pressure was also recorded
at the same intervals. Proteinuria had not been systematically
collected in the clinical charts, unless signiﬁcantly increased,
and was therefore not included in the original database.
At birth, data concerning Apgar score, weight, sex, centile
(according to Parazzini charts) and malformations were
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collected. The main maternal problems in pregnancy were also
recorded as free text.
Since the study period was very long (1978–December
2013), early pregnancy losses were collected in the database
but were not included in the present analysis in order to reduce
the reporting bias; similar considerations apply to miscarriages
after the 24th gestational week, which were collected but not in-
cluded in the analysis, which focused on live-born babies whose
data are less subject to reporting biases.
Deﬁnitions
Hypertension was deﬁned as systolic blood pressure ≥140
mmHg and/or diastolic blood pressure ≥90 mmHg or antihy-
pertensive therapy; patients on antihypertensive therapy prior
to conception were included even when antihypertensive ther-
apy was discontinued in pregnancy.
Due to the high prevalence of missing data on proteinuria at
baseline, and to the difﬁculties in deﬁning pre-eclampsia (PE)
or ‘superimposed PE’ in the context of pre-existing kidney dis-
ease, we did not include pre-eclampsia as an outcome in this
study [36, 37].
A newborn was deﬁned as SGA when the birthweight was
below the 5th or 10th centile according to the Italian birth-
weight references that were used most often throughout the
study period (Parazzini charts) [38].
Preterm delivery was deﬁned as delivery before 37 com-
pleted weeks of gestational age, ‘early’ preterm deliveries were
deﬁned as deliveries before 34 completed weeks and extreme
preterm delivery was deﬁned as delivery before the 28th com-
pleted gestational week [39–42].
Control group
The control group consisted of low-risk pregnancies re-
cruited in two Italian Units (Torino and Cagliari), and data
were updated on 31March 2015. This is an update of the Torino
Cagliari Observational Study (TOCOS) cohort, which can be
referred to for further details [43]. Low-risk cases are deﬁned
as pregnancies occurring in the absence of hypertension, obes-
ity, diabetes, CKD, cardiovascular diseases or any other disease
or condition potentially affecting pregnancy outcomes.
We chose for comparison 1421 patients (including 3 intra-
uterine deaths and 1418 singleton live-born deliveries) from
among 1484 low-risk singleton pregnancies (after excluding
39 miscarriages and 24 patients lost to follow-up).
Statistical analysis
A descriptive analysis was performed as appropriate (mean
and standard deviation for parametric data and median and
range for non-parametric data). Paired t-test, chi-square test,
Fisher’s test, Kruskal–Wallis test, Mann–Whitney U test, ana-
lysis of variance and t-test with Bonferroni correction were
used where indicated for comparisons between cases and con-
trols and among groups. Signiﬁcance was set at <0.05.
Multiple regression analysis was performed considering the
outcomes (i.e. preterm delivery, early preterm delivery, SGA
baby) and the following covariates: age, dichotomized at the
median (33 years), period of graft (dichotomized at 2000),
CKD stage at start of pregnancy (1–2 versus 3 and 1 versus
2–3) and hypertension at start of pregnancy (SPSS version
18.0 for Windows; SPSS, Chicago IL, USA).
Kaplan–Meier analysis was performed as time-to-event ana-
lysis, starting the observation at 24 weeks (previous deliveries
were considered miscarriages) and continuing until the date
of delivery. The analysis was performed as implemented on
SAS 9.2 (SAS Institute, Cary, NC, USA). Differences were as-
sessed by log-rank and Wilcoxson tests.
Ethical issues
The observational study protocol was performed in the con-
text of the institutional activities of the Study Group on Kidney
and Pregnancy of the Italian Society of Nephrology. The study
was approved by the ethics committee of San Luigi Gonzaga
Hospital of the University of Torino, Italy (nota
prot. n. 11655 del 26/06/13 - studio osservazionale pratica co-
mitato etico n. 90/2013 Delibera n. 363 del 17/06/13).
RESULTS
Baseline data
Overall, excluding abortions (before the 24th gestational
week: 4 cases), 219 pregnancies were reported (79 in 1978–99
and 136 in 2000–12). By also ruling out subjects for whom kid-
ney function data concerning the ﬁrst 12 weeks of pregnancy
(11 cases before and 15 cases after 2000) were not available,
and intrauterine deaths (1 case), 189 live-born babies were se-
lected for the present analysis: 68 who were born between 1978
and 1999 and 121 between 2000 and 2013.
Maternal age signiﬁcantly increased over time (in the ﬁrst per-
iod, median age was 30.7 ± 3.7 years versus 34.1 ± 3.7 in the se-
cond period; P < 0.001); kidney function was similar in both
periods (median serum creatinine 1.05 and 1.07, respectively,
with roughly half of the cases in stage 2 CKD in both periods),
as was the prevalence of themain kidney diseases. Approximately
half of the patients had baseline hypertension, with a non-
signiﬁcant increase from the ﬁrst to the second period.
Overall, 17.5% of the patients had received a living donor
graft, which was more frequently the case in the ﬁrst period
than in the second, albeit non-signiﬁcantly (Table 1).
Azathioprine, steroids and cyclosporine A were the main
drugs employed in the ﬁrst period, while tacrolimus emerged
in the second. In the ﬁrst period, about one-fourth of the pa-
tients were on calcineurin-free regimens versus 7.5% in the se-
cond; steroids were used in all patients in the ﬁrst period and in
90% in the second (Table 1).
Main maternal–foetal outcomes
Caesarean sections were almost the rule in this population,
even if a non-signiﬁcant trend towards a reduction was ob-
served (in parallel to what was observed in the overall popula-
tion in Italy [44]) (Table 2).
The overall prevalence of preterm babies (<37 gestational
weeks) was not signiﬁcantly different in the two periods (52.2
and 60.2%; P: ns), while the increase in early preterm delivery
was signiﬁcant (13.4 and 27.1%; P = 0.049) (Table 2). Conversely,
the incidence of SGA babies below the 5th centile signiﬁcantly
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decreased over time in the two time periods (22.2 versus 9.6%;
P = 0.036). As a consequence of increased prematurity but de-
creased SGA, birthweight was not signiﬁcantly different in the
two periods.
As expected, most of the outcomes differ signiﬁcantly with
respect to the low-risk controls (Table 2); the most important
differences were observed for prematurity, in particular for
early preterm delivery (22.2 versus 0.9%; P < 0.001) and for
SGA babies (<5th percentile: 14 versus 4.5%). The only excep-
tion is extreme preterm delivery (1.1 versus 0.1%, although not
reaching statistical signiﬁcance). The differences maintain a
high statistical signiﬁcance for all the previous items, even
when considering only stage 1 patients versus controls
(Table 2).
The results observed across CKD stages are reported in
Table 3. Of note, the duration of pregnancy decreased and
Table 1. Baseline characteristics of the study population: singleton live-born deliveries (with available baseline and birth data)
KT 1978–1999 KT 2000–2013 P-value before versus after 2000 All KT
Pregnancies, n 68 121 189
Age at pregnancy (years) 30.7 ± 3.7 34.1 ± 3.7 <0.001 32.8 ± 4.1
Glomerular, n (%) 25 (36.8) 62 (51.2) 0.078 87 (46)
Diabetic nephropathy, n (%) 2 (2.9) 4 (3.3) 0.768 6 (3.2)
Interstitial, n (%) 8 (11.8) 9 (7.4) 0.464 17(9)
ADPKD, n (%) 1 (0.8) 3 (2.5) 0.949 4 (2.1)
Stage 1, n (%) 14 (20.6) 26 (21.5) 0.487 40 (21.2)
Stage 2, n (%) 36 (52.9) 52 (43) 88 (46.6)
Stage 3, n (%) 18 (26.5) 42 (34.7) 60 (31.7)
Stages 4–5, n (%) 0 1 (0.8) 1 (0.5)
sCr (before or ﬁrst updating) 1.05 (0.6–1.8) 1.07 (0.6–2.4) 0.993 1.07 (0.6–2.4)
Hypertension at referral, n (%) 29 (42.6) 67 (55.4) 0.127 96 (50.8)
Pre-pregnancy follow-up
Median (min–max) 37.5 (0–192) 27.5 (0–194) 0.198 28 (0.194)
Pre-emptive, n (%) 2 (2.9) 6 (5) 0.780 8 (4.2)
Living donor KT, n (%) 15 (22.1) 18 (14.9) 0.294 33 (17.5)
Treatment with CyA, n (%) 50 (74.6) 62 (51.7) 0.004 112 (59.9)
Treatment with tacrolimus, n (%) 1 (1.5) 49 (40.8) <0.001 50 (26.7)
No calcineurin inhibitors, n (%) 16/67 (23.9) 9/120 (7.5) 0.003 25/187 (13.4)
Treatment with steroids, n (%) 67/67 (100) 108/120 (90) 0.018 175/187 (93.6)
Months between KT and pregnancy, median (min–max) 52 (5–178) 62 (14–278) 0.086 59 (5–278)
1418 low-risk controls; age 31.2 ± 5.6 years (P < 0.001 versus transplantation).
ADPKD: autosomic dominant polycystic kidney disease; KT: kidney transplantation; CyA: cyclosporine A; sCr: serum creatinine; min: minimum; max: maximum. Pre-pregnancy: follow-
up on dialysis before renal transplant (months of dialysis). Pre-post: pregnancy with delivery before or after 2000.
Table 2. Deliveries according to period of analysis: all cases, stage 1 only versus low-risk controls
KT 1978–1999 KT 2000–2013 P-values before
versusafter 2000
KT all cases Controls P-values, all KT
low-riskcontrols
Kidney transplantation: all stages versus controls
Pregnancies, n 68 121 – 189 1418
Age at pregnancy (years) 30.71 ± 3.72 34.06 ± 3.73 <0.001 32.85 ± 4.05 31.2 ± 5.6 <0.001
Caesarean section 60/67 (89.6%) 95/121 (79.2%) 0.108 155/187 (82.9%) 379/1418 (26.7%) <0.001
Gestational week 36.15 ± 2.63 35.32 ± 2.97 0.060 35.62 ± 2.88 39 ± 1.7 <0.001
Preterm (<37 weeks) 35/67 (52.2%) 71/118 (60.2%) 0.372 106/185 (57.3%) 89/1418 (6.3%) <0.001
Early preterm (<34 weeks) 9/67 (13.4%) 32/118 (27.1%) 0.049 41/185 (22.2%) 13/1418 (0.9%) <0.001
Extreme preterm (<28 weeks) 0 2/118 (1.7%) 0.535 2/185 (1.1%) 2/1418 (0.1%) 0.068
Weight at birth (g) 2458.38 ± 547 2399.61 ± 686 0.530 2420 ± 640 3232 ± 476 <0.001
SGA <10% (Parazzini) 19/63 (30.2%) 24/115 (20.9%) 0.230 43/178 (24.2%) 157/1413 (11.1%) <0.001
SGA <5% (Parazzini) 14/63 (22.2%) 11/115 (9.6%) 0.036 25/178 (14%) 63/1413 (4.5%) <0.001
Kidney transplantation: stage 1 versus controls
Pregnancies, n 14 26 40 1418
Age at pregnancy (years) 30.2 ± 2.9 33.4 ± 4.4 0.019 31.24 ± 5.6 31.2 ± 5.6 0.126
Caesarean section 11/14 (78.6%) 19/26 (73.1%) 0.999 30/40 (75%) 379/1418 (26.7%) <0.001
Gestational week 37.86 ± 1.5 36 ± 3.2 0.047 36.65 ± 2.8 39 ± 1.7 <0.001
Preterm (<37 weeks) 2/14 (14.3%) 12/26 (46.2%) 0.081 14/40 (35%) 89/1418 (6.3%) <0.001
Early preterm (<34 weeks) 0 4/26 (15.4%) 0.278 4/40 (10%) 13/1418 (0.9%) <0.001
Extreme preterm (<28 weeks) 0 1/26 (3.8%) 1.000 1/40 (2.5%) 2/1418 (0.1%) 0.080
Birthweight (g) 2706 ± 406 2573.6 ± 810 0.582 2619 ± 695 3232 ± 476 <0.001
SGA <10% (Parazzini) 6/13 (46.2%) 6/25 (24%) 0.055 12/38 (31.6%) 157/1413 (11.1%) <0.001
SGA <5% (Parazzini) 5/13 (38.5%) 4/25 (16%) 0.026 9/38 (23.7%) 63/1413 (4.5%) <0.001
Parazzini: growth curves according to Parazzini et al. [38]; KT: kidney transplantation.
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the risk of prematurity increased across CKD stages, while the
prevalence of SGA babies did not vary signiﬁcantly (Table 3).
A decrease in kidney function from the ﬁrst to the last update
in pregnancy, leading to a ‘stage shift’ from a lower to a higher
CKD stage, was recorded overall in ∼18% of the cases in both
periods (18.5 versus 18%; P: ns). One intrauterine death was re-
ported in the transplant group and three in the low-risk popu-
lation; in the second period, none of the babies died in the ﬁrst
month of life.
Kidney function 1 year after delivery
Table 4 reports the functional data of the transplanted
women 6 months and 1 year after delivery. None of the
women died in the ﬁrst year after delivery and only one started
dialysis within 1 year (age 29 years; baseline disease: glomerulo-
nephritis, hypertensive at the start of pregnancy, serum creatin-
ine 1.5 mg/dL at the 20th gestational week and 3.4 mg/dL at the
end of pregnancy; she delivered a female baby at 32 gestational
weeks, adequate for gestational age; she died of a cerebral acci-
dent 2 years after delivery).
Within the limits of retrospective collections, the data sug-
gest that kidney transplant patients who start pregnancy in
CKD stages 2–3 do not necessarily undergo worsening of
renal function either during pregnancy (Table 3) or after deliv-
ery (Table 4).
Logistic regression and time to delivery analysis
Logistic regression analysis, undertaken for the most im-
portant outcomes, conﬁrms the importance of the classic ele-
ments associated with pregnancy outcomes in CKD patients,
i.e. being in stages 2–5 bears a 3-fold risk for preterm delivery
as compared with stage 1 CKD, the presence of non-signiﬁcant
increases in the risk of being SGA and of prematurity, a correl-
ation that becomes signiﬁcant in the combined outcome.
Interestingly, the second study period is associated with a
higher risk of early preterm birth and a lower risk of delivering
an SGA baby (below the 5th centile). The difference depending
on the study period is offset if we consider combined outcomes
by merging data for preterm delivery and SGA babies (Table 5).
The relationship between time of delivery, birthweight and
study period is graphically depicted in Figure 1. Follow-up
starts at 24 weeks (due to the exclusion of abortions); the rele-
vant difference between the curves is for the period between 31
and 36 weeks. However, statistical signiﬁcance is not reached,
although it is borderline by Wilcoxon’s test, which is more sen-
sitive to ‘geometric’ variations of the curves.
Figures 2 and 3 report the birthweight and growth curves at
delivery in male and female newborns in the same period: the
ﬁgures suggest a different policy towards delivery in the ﬁrst
period (more small babies with older gestational age) as com-
pared to the second period (babies are delivered before
becoming growth restricted).
DISCUSSION
Pregnancy after kidney transplantation is proof of success, but it
is not devoid of risks; patient counselling is essential [5, 7–13]. Ta
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However, even if the history of pregnancy after kidney
transplantation is very long, our knowledge is still incomplete
[14, 21].
Available data share the limits of observational studies and
come from a few large, mostly voluntary registries, and from
many smaller more homogeneous series that are subject to a
strong ‘centre effect’, also mirroring social, ﬁnancial andmedical
differences [21]. Obstetric policies vary widely around the world,
and this may be relevant in analysing the results [45–49].
In this context, the present study was undertaken to account
for the lack of a systematic study in our country; it was initially
aimed at censusing the ‘children of transplantation’, analogous
to a previous study on the ‘children of dialysis’, and was further
developed to try to understand the differences that were re-
ported over two macro periods (1978–99 and 2000–13) [31].
Over time, patients’ age signiﬁcantly increased, while dis-
eases causing uraemia, kidney function at start of pregnancy
and the prevalence of hypertension remained unchanged,
possibly reﬂecting the lack of substantial changes in the
young female population starting RRT in Italy and/or a policy
of conservative counselling for pregnancy (good renal function,
no hypertension) [8, 9, 11, 12, 50, 51]. In keeping with what
is observed in the overall transplanted population in our
country, in the new millennium therapy has shifted from
cyclosporine to tacrolimus, steroid use decreased while calci-
neurin use increased, living donations decreased and there
has been an increase in pre-emptive transplantation (Table 1)
[3, 19, 21].
As expected, pregnancy outcomes of women with kidney
transplantation differ signiﬁcantly from those of low-risk preg-
nancies, and the differences are signiﬁcant evenwhen considering
patients with normal kidney function (stage 1 patients) (Table 2).
In keeping with what is observed in the non-transplanted CKD
population, there is a signiﬁcant relationship between CKD stages
Table 4. Kidney functional data over pregnancy and up to 12 months after delivery
KT 1978–1999 KT 2000–2013 All cases P-value, before and after 2000
Patients, n 68 121 189
sCr before pregnancy 1.05 (0.51–1.8) 1.07 (0.6–2.4) 1.07 (0.51–2.4) 0.993
sCr 20 weeks 0.9 (0.5–1.9)
N = 53
0.9 (0.4–2.3)
N = 93
0.9 (0.4–2.3)
N = 146
0.642
sCr 6 months after delivery 1.0 (0.4–2.1)
N = 55
1.0 (0.6–2.5)
N = 89
1.0 (0.4–2.5)
N = 144
0.749
sCr 1 year after delivery 1.1 (0.4–2.1)
N = 61
1.1 (0.5–2.6)
N = 102
1.1 (0.4–2.6)
N = 163
0.543
eGFR CKD-EPI before pregnancy 72 (36–129) 71 (25–123) 71 (25–129) 0.473
eGFR CKD-EPI 20 weeks 86 (36–132)
N = 53
80 (27–133)
N = 93
82 (27–133)
N = 146
0.238
eGFR CKD-EPI 6 months after delivery 73 (31–142)
N = 55
71 (24–123)
N = 89
71.5 (24–142)
N = 144
0.425
eGFR CKD-EPI 1 year after delivery 67 (31–141)
N = 61
66.5 (22–133)
N = 102
67 (22–141)
N = 163
0.997
CKD-EPI stages before pregnancy
Stage 1 14/68 (20.6%) 26/121 (21.5%) 40/189 (21.2%) 0.487
Stage 2 36/68 (52.9%) 52/121 (43.0%) 88/189 (46.6%)
Stage 3 18/68 (26.5%) 42/121 (34.7%) 60/189 (31.7%)
Stages 4–5 – 1/121 (0.8%) 1/189 (0.5%)
CKD-EPI stages 1 year after delivery
Stage 1 7/61 (11.5%) 17/102 (16.7%) 24/163 (14.7%) 0.188
Stage 2 36/61 (59.0%) 48/102 (47.1%) 84/163 (51.5%)
Stage 3 18/61 (29.5%) 32/102 (31.4%) 50/163 (30.7%)
Stages 4–5 – 5/102 (4.9%) 5/163 (3.1%)
Data expressed as median (minimum-maximum); sCr: serum creatinine; eGFR: estimated glomerular ﬁltration rate; CKD-EPI: Chronic Kidney Disease Epidemiology Collaboration; KT:
kidney transplantation.
In 1978–99: information on outcomes available in 45 cases. Dialysis was restarted by 25 women after delivery (nonewithin the ﬁrst year); 6mothers died (none in the ﬁrst year after delivery).
In 2000–13: dialysis was restarted by 9 women after delivery (one only within the ﬁrst year); 2 mothers died (1 after dialysis start, 2 years after delivery, and one 3 years after delivery).
Table 5. Multiple regression results: KT patients in the different CKD stages (ORs and CIs)
Pretermdelivery
<34 weeks
Preterm delivery
<37 weeks
SGA <10th
centile
SGA <5th
centile
Preterm delivery <37 weeks
and/or SGA <10th centile
Preterm delivery <34 weeks
and/or SGA <5th centile
KT CKD stage
1
1 1 1 1 1 1
KTCKD stages
2–5
3.2 (1.06–9.72) 3.39 (1.61–7.12) 0.65 (0.29–1.46) 0.42 (0.16–1.09) 1.94 (0.93–4.06) 1.34 (0.62–2.86)
Normal BP 1 1 1 1 1 1
High BP 1.07 (0.52–2.19) 1.45 (0.79–2.66) 1.78 (0.87–3.66) 1.68 (0.68–4.15) 2.00 (1.05–3.80) 1.37 (0.74–2.55)
KT 1978–1999 1 1 1 1 1 1
KT 2000–2013 2.45 (1.07–5.59) 1.36 (0.73–2.56) 0.55 (0.27–1.14) 0.33 (0.14–0.80) 0.88 (0.46–1.72) 0.98 (0.52–1.86)
1: reference; Parazzini: growth curves according to Parazzini et al. [38]; KT: kidney transplantation; BP: blood pressure.
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and pregnancy-related outcomes, with an overall increase in ad-
verse outcomes with increasing CKD stage (Table 3).
Of note, kidney function worseningmay be less frequent than
previously reported since ‘stage shifts’ from pre-pregnancy to
1 year after delivery occurred in only ∼20% of patients (Table 4).
The main point of interest in our study is highlights the two
main differences in pregnancy-related outcomes over time: the
incidence of ‘early preterm’ deliveries almost doubled over
time, but conversely, the incidence of SGA age babies decreased
by almost 70% in the second period. Interestingly, when these
merge into a combined outcome, either ‘general’ (preterm deliv-
ery and/or SGA <10th centile) or ‘severe’ (early preterm and/or
SGA <5th centile), no differences over time are observed, thus
suggesting that the two outcomes are interrelated and an increase
in one compensates for a decrease in the other (Tables 2, 3 and 5).
This interpretation may be supported by the changes in ob-
stetric policies that have been made in recent decades [52–54].
Our hypothesis is that the greater attention to utero-placental
ﬂow and foetal growth has led to earlier delivery in the presence
of initial growth impairment, even before the baby becomes
SGA (Figures 1–3). In keeping with this hypothesis, the differ-
ence is mainly observed at 32–35 weeks (during which the ob-
stetric choices play a major role) after having reached the ﬁrst
major developmental goals (28–32 gestational weeks; Figure 1)
[55]. The main impact of this ﬁnding is to suggest contextual-
izing data employed for counselling to similar periods of time
and clinical settings, with particular attention on obstetric pol-
icy, which is particularly important in modulating the results of
late preterm babies.
The main strength of our study, which is the ﬁrst compre-
hensive Italian survey, is that it evaluates ∼35 years of observa-
tion, the novelty is that it compares results over time and the
advantage is that it relates data with a dataset from a large, low-
risk population. However, it has several weaknesses: it is retro-
spective and therefore some important outcomes, such as early
foetal loss, were not evaluable; it has a large, but incomplete na-
tionwide enrolment (coverage of ∼60% in the ﬁrst period and
80% in the second period); some important information such as
proteinuria before and during pregnancy and long-term follow-
up of the babies is not available. These biases are, however,
shared by most of the largest datasets, which are derived from
voluntary registries, and share the same problem of incomplete
coverage [21].
While acknowledging these limitations, the study group
hopes that this ﬁrst analysis might be the basis for a systematic,
prospective evaluation of pregnancies after kidney transplant-
ation in Italy.
CONCLUSIONS
The main features of women delivering a live-born baby after
kidney transplantation have changed over time, with a signiﬁ-
cant increase in maternal age and a shift from cyclosporine to
tacrolimus in the new millennium.
In spite of high prematurity rates, no perinatal deaths were
reported, thus conﬁrming an overall good prognosis in
F IGURE 1 : Time to event (delivery) analysis, from 24 to 41 gesta-
tional weeks (live-born deliveries, singletons).
F IGURE 2 : Birth weight and growth curves at delivery in male
newborns.
F IGURE 3 : Birth weight and growth curves at delivery in female
newborns.
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pregnancies that continue after the ﬁrst 24 weeks of gestation. In
both periods, graft loss did not appear to increase after delivery.
In this context, the incidence of ‘early preterm’ deliveries al-
most doubled over time and was counterbalanced by a corre-
sponding decrease in SGA babies. We therefore suggest that
increased obstetric attention may have led to earlier delivery of
babies whose in utero growth slowed. These variations should
be kept in mind when comparing data obtained in different per-
iods and in different settings and underline the need for careful
contextualization of the results that are used when counselling
our patients. Further prospective studies are needed to highlight
the pathophysiological mechanisms that are the basis of the ob-
served results, and to compare different populations, including
not only low-risk controls, but also other CKD stages and phases,
observed in similar settings and over comparable periods of time.
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